ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CABA vs OCGN // DIVIDEND YIELD & FCF PAYOUT SAFETY

Cabaletta Bio Inc. (NASDAQ) VS. Ocugen Inc. (NASDAQ) • 15-METRIC TALLY: CABA 2 — OCGN 1
■ METRIC PARITY
dividend-safety
0.00%
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CABA VS. OCGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CABA OCGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -22.65% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 8.80% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 OCGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.6 31.7 +6.90 CABA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $256.0M $238.3M $17.7M CABA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CABA REV OCGN REV CABA GROSS % OCGN GROSS % CABA FCF OCGN FCF
FY 2025 $482.3M $4.4M — — -$132.3M -$57.1M
FY 2024 $350.4M $4.1M — — -$90.4M -$45.5M
FY 2023 $209.0M $6.0M — — -$53.5M -$62.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CABA // BETA —
OCGN // BETA —